REGN Financials

Regeneron Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$781.67

Market Cap

$82.64B

P/E Ratio

18.8

EPS

$41.51

Income Statement Highlights

Most Recent Quarter: FY

Revenue

$14.34B

Gross Profit

Operating Income

$3.58B

Net Income

$4.50B

EPS (Diluted)

$41.48

Balance Sheet Highlights

Total Assets

$40.56B

Total Liabilities

$9.30B

Shareholders Equity

$31.26B

Cash & Equivalents

$3.12B

Total Debt

Cash Flow Highlights

Operating Cash Flow

$4.98B

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

44.6%

Operating Margin

0.2%

Net Margin

0.3%

ROE

0.1%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is REGN revenue?

REGN's most recent quarterly revenue was $14.34B. Annual revenue can be calculated by summing the four most recent quarters.

Is REGN profitable?

REGN reported a profit of $4.50B in the most recent quarter. The net profit margin is 0.3%.

What is REGN market cap?

REGN has a market capitalization of $82.64B, making it a large-cap stock.

Does REGN have debt?

View REGN's balance sheet for debt information.

What is REGN cash flow?

Cash flow data is available in the full financial statements.